Form 424B5 ARTELO BIOSCIENCES, INC.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Artelo Biosciences files $6.5M at-the-market offering prospectus
May 26, 2026 4:50 PM EDTArtelo Biosciences (NASDAQ: ARTL) filed a prospectus supplement for an at-the-market offering program to sell up to $6.53 million of common stock through H.C. Wainwright & Co. as exclusive sales agent.
The biotechnology company entered into an At the Market Offering Agreement with H.C. Wainwright dated... More
